Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3–5 patients with asymptomatic hyperuricemia: a network meta-analysis

Objective This study evaluates and compares the effectiveness and safety of febuxostat and allopurinol in chronic kidney disease (CKD) stages 3–5 patients with asymptomatic hyperuricemia using a network meta-analysis.Methods A systematic review and network meta-analysis were conducted, adhering to P...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaojiao Chen, Yanyun Zhang, Yinglin Wang, Lu Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2025.2470478
Tags: Add Tag
No Tags, Be the first to tag this record!